FCN2 and diffuse large B-cell lymphoma: FCN2 was found to be favorably linked to the majority of immunomodulators, chemokines, and other factors, as well as the chemokine receptors in LIHC and diffuse large B-cell lymphoma (DLBCL), and negatively correlated with most of the immunomodulators, chemokines, and chemokine receptors in THYM and TGCT.